Brief: Oncternal Therapeutics Inc - On April 4, Received Notice From Nasdaq That Co Is Not Been In Compliance With Minimum Bid Price Requirement
06/04/2023 22:15
April 6 (Reuters) - Oncternal Therapeutics Inc ONCT.O :
* ONCTERNAL THERAPEUTICS INC - ON APRIL 4, RECEIVED NOTICE
FROM
NASDAQ THAT CO IS NOT BEEN IN COMPLIANCE WITH MINIMUM BID PRICE
REQUIREMENT
Further company coverage: ONCT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oncternal Therapeutics
See all newsOncternal Therapeutics Inc expected to post a loss of $3.19 a share - Earnings Preview
Brief: Oncternal Therapeutics Workforce Reduction Of About 10 Employees
U.S. STOCKS ON THE MOVE-Unity Software, Viking Holdings, Adobe
U.S. STOCKS ON THE MOVE-Gold miners, silver miners, Warner Bros Discovery
Oncternal hits record low on plans to scrap studies, explore strategic alternatives;